Craft

Advanced
  • Home
  •  / Zenith Epigenetics
Zenith Epigenetics

Zenith Epigenetics

Zenith Epigenetics Summary

Company Summary

Overview
Zenith Epigenetics is a biotechnology company developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders. It offers a pan selective BET inhibitor for patients suffering from solid tumors, including prostate cancer.
Type
Subsidiary
Status
Active
Founded
2013
HQ
San Francisco, CA, US | view all locations
Website
https://www.zenithepigenetics.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Donald J. McCaffrey

    Donald J. McCaffrey, President and Chief Executive Officer, Chairman of the Board

    • Kelly McNeill

      Kelly McNeill, Director

      • Sanjay Lakhotia

        Sanjay Lakhotia, Chief Business Officer

        • Eldon R. Smith

          Eldon R. Smith, Director

          LocationsView all

          2 locations detected

          • San Francisco, CA HQ

            United States

            44 Montgomery, 44 Montgomery St #4010, San Francisco

          • Calgary, AB

            Canada

            4820 Richard Rd SW #300

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX